These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19853417)

  • 21. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.
    Leuchter AF; McGough JJ; Korb AS; Hunter AM; Glaser PE; Deldar A; Durell TM; Cook IA
    J Psychiatr Res; 2014 Jul; 54():11-8. PubMed ID: 24726639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.
    Leuchter AF; Morgan M; Cook IA; Dunkin J; Abrams M; Witte E
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):15-22. PubMed ID: 15252704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.
    Nelson JC; Zhang Q; Deberdt W; Marangell LB; Karamustafalioglu O; Lipkovich IA
    Curr Med Res Opin; 2012 Mar; 28(3):325-34. PubMed ID: 22292447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
    Manber R; Kraemer HC; Arnow BA; Trivedi MH; Rush AJ; Thase ME; Rothbaum BO; Klein DN; Kocsis JH; Gelenberg AJ; Keller ME
    J Consult Clin Psychol; 2008 Jun; 76(3):459-67. PubMed ID: 18540739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder?
    Cook IA; Hunter AM; Korb AS; Leuchter AF
    J Psychiatr Res; 2014 Jun; 53():69-75. PubMed ID: 24630467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.
    Helmreich I; Wagner S; König J; Kohnen R; Szegedi A; Hiemke C; Tadić A
    J Affect Disord; 2015 Apr; 175():199-208. PubMed ID: 25638793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.
    Fann JR; Bombardier CH; Temkin N; Esselman P; Warms C; Barber J; Dikmen S
    J Head Trauma Rehabil; 2017; 32(5):332-342. PubMed ID: 28520672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
    Morgan ML; Cook IA; Rapkin AJ; Leuchter AF
    Maturitas; 2007 Jan; 56(1):54-60. PubMed ID: 16835012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder.
    Iosifescu DV; Greenwald S; Devlin P; Perlis RH; Denninger JW; Alpert JE; Fava M
    Acta Psychiatr Scand; 2008 Apr; 117(4):271-6. PubMed ID: 18307587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder.
    Soares CN; Endicott J; Boucher M; Fayyad RS; Guico-Pabia CJ
    CNS Spectr; 2014 Dec; 19(6):519-27. PubMed ID: 24571916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.
    Baskaran A; Farzan F; Milev R; Brenner CA; Alturi S; Pat McAndrews M; Blier P; Evans K; Foster JA; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Strother SC; Turecki G; Kennedy SH;
    J Affect Disord; 2018 Feb; 227():542-549. PubMed ID: 29169123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
    Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
    EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
    Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
    Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.
    Hunter AM; Leuchter AF; Cook IA; Abrams M; Siegman BE; Furst DE; Chappell AS
    Pain Med; 2009; 10(4):730-8. PubMed ID: 19453962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.
    Korb AS; Hunter AM; Cook IA; Leuchter AF
    Psychiatry Res; 2011 Jun; 192(3):188-94. PubMed ID: 21546222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In patients suffering from major depressive disorders, quantitative EEG showed favorable changes in left and right prefrontal cortex.
    Haghighi M; Ludyga S; Rahimi B; Jahangard L; Ahmadpanah M; Torabian S; Esnaashari F; Nazaribadie M; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2017 May; 251():137-141. PubMed ID: 28199912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication.
    Chung KF; Yu YM; Yeung WF
    J Affect Disord; 2015 Nov; 186():192-7. PubMed ID: 26247911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.